Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

FDA Approves First Generic Aricept to Treat Dementia Related to Alzheimer’s Disease

December 15, 2009 7:13 am | News | Comments

The FDA approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablet s on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer’s disease.

TOPICS:

Celgene Psoriasis Drug Meets Midstage Study Goal

December 15, 2009 6:56 am | News | Comments

SUMMIT, N.J. (AP) — Biotechnology company Celgene Corp. said Tuesday its experimental psoriasis treatment, apremilast, met key goals in a midstage clinical trial. The company said apremilast reduced the severity of moderate-to-severe psoriasis during the study.

800,000 Doses of Kids' Swine Flu Vaccine Recalled

December 15, 2009 6:53 am | News | Comments

MIKE STOBBE AP Medical Writer ATLANTA (AP) — Health officials are recalling hundreds of thousands of doses of swine flu vaccine after tests indicated they may not be potent enough to protect against the virus. The Centers for Disease Control and Prevention notified doctors about the recall Tuesday.

TOPICS:
Advertisement

FDA Expands Presence Outside U.S. with Opening of Mexico City Post

December 15, 2009 6:14 am | News | Comments

As part of its continuing effort to buttress food and medical product safety in this country by working with its regulatory partners overseas, the U.S. Food and Drug Administration today announced the opening of its Mexico City post.

TOPICS:

Schreiner MediPharm is Honored with the Wyeth GROWS Award for Continuous Improvement

December 15, 2009 5:54 am | News | Comments

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 50 years, was recently presented with Wyeth's “Global Recognition for Outstanding Wyeth Suppliers” (GROWS) Award at a ceremony in Munich, Germany.

TOPICS:

Takeda and Pfizer to Co-Promote Takeda’s Actos® (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China

December 15, 2009 4:40 am | News | Comments

Takeda Pharmaceutical Company Limited and Pfizer Inc. have announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda’s Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.

TOPICS:

FDA Says OSI Drug Effective Against Lung Cancer

December 15, 2009 4:15 am | News | Comments

MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy.

TOPICS:

Teva Hails Milder Restrictions on Parkinson's drug

December 15, 2009 4:06 am | News | Comments

NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Monday U.S. health regulators scaled back dietary and health restrictions on its Parkinson's Disease drug Azilect.

TOPICS:
Advertisement

Gilead's Blood Pressure Drug Candidate Falls Short in Trial

December 15, 2009 4:00 am | News | Comments

FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. said Tuesday its high blood pressure treatment candidate, darusentan, failed to meet the main goal of a late-stage clinical trial when compared to a placebo.

TOPICS:

Array BioPharma and Amgen Partner in Type 2 Diabetes

December 15, 2009 3:57 am | News | Comments

Array BioPharma Inc. and Amgen Inc.have entered into an agreement granting Amgen exclusive worldwide rights to Array's small-molecule glucokinase activator program, including ARRY-403, currently being tested in a Phase 1 clinical trial in patients with Type 2 diabetes.

TOPICS:

Abbott to Acquire STARLIMS Technologies Ltd., a Provider of Laboratory Information Management Systems

December 15, 2009 3:54 am | News | Comments

Abbott announced today a definitive agreement to acquire STARLIMS Technologies Ltd., a provider of laboratory information management systems, for approximately $123 million in cash.

TOPICS:

Novel Drug Combo Improves Breast Cancer Survival

December 14, 2009 4:21 am | News | Comments

MARILYNN MARCHIONE AP Medical Writer SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option.

TOPICS:

Basilea's Toctino Recommended for Approval in 15 Additional European Countries

December 14, 2009 4:16 am | News | Comments

Basilea Pharmaceutica Ltd announces that Toctino (alitretinoin) was recommended for regulatory approval under the Repeat-use Procedure in 13 additional European Union (EU) Member States as well as in Norway and Iceland.

TOPICS:

FDA Grants Emergency Use Authorization for DxNA's GeneSTAT(TM) Integrated PCR-based Influenza Detection System for H1N1 Virus

December 14, 2009 3:54 am | News | Comments

DxNA announced today that the FDA has granted Emergency UseAuthorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for usein DxNA's GeneSTAT(TM) detection platform.

TOPICS:

Cubist Pharmaceuticals Pays $92.5M for Calixa

December 14, 2009 3:51 am | News | Comments

LEXINGTON, Mass. (AP) — Cubist Pharmaceuticals Inc. said today it will pay $92.5 million in cash to buy biopharmaceutical company Calixa Therapeutics Inc. in a deal it expects to close this month.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading